Skip to main content

Table 2 Results from the laboratory studies

From: Reliability and validity of a novel Kinect-based software program for measuring posture, balance and side-bending

 

Data

Differences1)

Relative reliability

Relative validity

Absolute reliability

Reliability study

Validity study

Reliability

Validity

 

Qinematic™

TEST 1

Median (IQR)

Qinematic™

TEST 2

Median (IQR)

BTS-Elite

Median (IQR)

Qinematic™

Median (IQR)

Qinematic™

T1 vs. T2

p-value1

Qinematic™ vs. BTS-Elite

p-value1

Qinematic™

T1 vs. T2

ICC2) (95%CI)

Qinematic™ vs. BTS-Elite

r (p-value)3)

Qinematic™ vs BTS-Elite

ICC2) (95%CI)

Qinematic™

SEM4)

Qinematic™

MCD5)

Posture (Reliability study: n = 37; Validity study: n = 26)

 P-HL

1.34 (2.42)

2.14 (1.71)

−0.53 (2.45)

0.79 (2.85)

0.230

0.000

0.329 (0.01–0.59)

0.487(0.014)

0.418 (0.04–0.72)

1.388

3.846

 P-HF

2.28 (6.52)

2.05 (5.46)

7.46 (5.89)

2.31 (5.63)

0.934

0.000

0.326 (0.01–0.59)

0.723 (0.000)

0.741 (0.49–0.64)

3.217

8.918

 P-PP

0.45 (1.13)

0.49 (0.79)

−0.08 (1.52)

0.45 (0.90)

0.028

0.032

0.308 (−0.01–0.57)

0.270 (0.181)

0.342(0.04–0.64)

0.619

1.717

 P-NA

−2.85 (6.26)

−2.76 (4.43)

0.054

0.723 (0.53–0.85)

1.876

5.200

 P-HL

0.33 (0.32)

0.32 (0.24)

0.354

0.655 (0.42–0.81)

0.122

0.339

 P-WB

48.52 (7.00)

46.95 (3.96)

49.16 (9.14)

48.96 (4.51)

0.041

0.259

0.231 (−0.10–0.52)

−0.073 (0.716)

−0.047 (−0.41–0.33)

3.372

9.349

Balance -Double stance (Reliability study: n = 37; Validity study: n = 26)

 DS-SA

0.10 (0.10)

0.10 (0.10)

0.12 (0.23)

0.10 (0.025)

0.591

0.069

0.125 (−0.20–0.43)

0.345 (0.084)

0.347 (−0.04–0.64)

0.632

1.752

 DS-SVAP

0.70 (0.50)

0.60 (0.30)

3.36 (1.17)

0.55 (0.525)

0.532

0.000

0.013 (−0.20–0.43)

−0.273 (0.178)

−0.039 (−0.41–0.35)

1.094

3.033

 DS-SVML

0.30 (0.15)

0.30 (0.30)

3.94 (0.88)

0.20 (0.1)

0.481

0.000

0.013 (−0.30–0.33)

0.159 (0.438)

0.038 (−0.35–0.41)

0.810

2.244

Balance - single stance, left (Reliability study: n = 37; Validity study: n = 24)

 SSL-SA

0.50 (0.70)

0.60 (0.40)

1.27 (1.85)

0.35 (0.58)

0.523

0.000

0.177 (−0.18–0.47)

0.301 (0.153)

0.111 (−0.30–0.49)

0.648

1.797

 SSL-SVAP

1.20 (0.85)

1.30 (0.50)

8.89 (3.83)

1.25 (0.95)

0.521

0.000

0.228 (−0.10–0.51)

−0.115 (0.465)

−0.008 (−0.40–0.39)

0.503

1.393

 SSL-SVML

1.40 (1.30)

1.30 (0.75)

8.89 (4.02)

1.25 (1.08)

0.631

0.000

0.162 (−0.17–0.46)

−0.087 (0.702)

−0.019 (−0.41–0.38)

0.684

1.896

Balance Single stance, right (Reliability study: n = 37; Validity study: n = 25)

 SSR-SA

0.50 (0.70)

0.50 (0.50)

0.87 (1.09)

0.40 (0.90)

0.432

0.003

−0.101 (−0.41–0.23)

0.260 (0.209)

0.422 (0.04–0.70)

0.907

2.515

 SSR-SVAP

1.20 (0.75)

1.20 (0.55)

8.63 (3.99)

1.30 (0.90)

0.700

0.000

0.048 (−0.28–0.36)

0.316 (0.124)

0.011 (−0.38–0.40)

0.557

1.545

 SSR-SVML

1.40 (1.00)

1.20 (0.75)

8.04 (4.41)

1.40 (1.30)

0.341

0.000

−0.094 (−0.40–0.23)

0.640 (0.001)

0.305 (−0.09–0.62)

1.016

2.816

Side-bending (Reliability study: n = 37; Validity study: n = 29)

 SB-LF

29.93 (3.09)

28.95 (3.21)

29.04 (5.78)

23.16 (5.83)

0.000

0.000

0.898 (0.81–0.95)

0.943 (0.000)

0.931 (0.86–0.95)

0.796

2.207

 SB-RF

29.77 (3.33)

28.92 (3.82)

29.70 (5.13)

23.79 (6.38)

0.018

0.259

0.394 (0.08–0.63)

0.888 (0.000)

0.904 (0.81–0.95)

2.215

6.134

 SB-%BW

85.01 (14.15)

84.18 (10.87)

0.105

 

0.693 (0.48–0.83)

 

5.700

15.799

  1. 1) Wilcoxon signed rank test. 2) ICC [1, 3], 3) Spearman correlation coefficient, 4) SEM = 2*SD*ICC, 5) MCD = √2 * SEM
  2. * Numbers in bold: p < 0.05
  3. Median and interquartile range (IQR) together with the reliability and construct validity statistics. Intraclass correlation (ICC [1, 3]) with significant ICC in bold, Spearman correlation (r) (p-value), Standard error of the measurement (SEM) and the Minimal Clinical Difference (MCD). Test-retest reliability statistics were calculated from the data from Test 1 (T1) and Test 2 (T2), and the construct validity statistics were calculated from data from Qinematic™ and BTS-Elite. See Table 1 for description of the variables